China's Animal Unit to Buy Pig Vaccine Company

According to The Business Times, the sale price took into consideration, amongst other factors, the potential of the vaccine for porcine reproductive respiratory syndrome developed by Jianxiang.

China Animal said the board feels the acquisition is in the best interest of the group and will further expand the range of its biological animal drug products, which include vaccines for swine fever and other livestock vaccines for immunisation against common diseases and viruses.

ThePigSite News Desk

Sign up for our
regular news updates

Related news items:

•    Third TOPIGS Import into China in Three Months
•    OleoServ Takes over Harles & Jentzsch Assets
•    Nutreco Achieves Excellent Progress in 2011
•    New Zealand Pork Seeks New CEO
•    Two Cases of ASF in Wild Boar

Related News Categories: Pig Health, Company/Products

Sign up for our
regular news updates

More of the latest Pig Industry News

•   CME: Changes for Beef, Pork & Poultry Supplies
•   Action Taken to Ramp Up Abattoir Inspections
•   FAO Food Price Index Rebounds in January
•   US Pork Export Forecast is Unchanged
•   Public Resistance Ousts GM Crops From EU
•   Animal Welfare: The Right Thing to Do
•   2011 Pork Imports Higher Than a Year Ago
•   New Way to Map Drought and Water Use
•   Nutreco CEO to Step Down at End of 2012
•   Importers Face High Stocks & Weak Demand